UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 10, 2004
| | |
Lifecore Biomedical, Inc. |
|
(Exact name of Registrant as specified in its charter) |
| | | | |
Minnesota | | O-4136 | | 41-0948334 |
| |
| |
|
(State or other jurisdiction of | | (Commission File Number) | | (IRS Employer Identification No.) |
incorporation or organization) | | | | |
| | |
3515 Lyman Boulevard | | |
Chaska, Minnesota | | 55318 |
| |
|
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: 952-368-4300
TABLE OF CONTENTS
Item 7. Financial Statements and Exhibits
(c) The following exhibit is being furnished herewith:
99.1 Press release dated February 10, 2004
Item 9. Regulation FD Disclosure
On February 10, 2004 Lifecore Biomedical, Inc. (“Lifecore”) issued a press release which announced today that Dennis J. Allingham has been appointed President and Chief Executive Officer and to the Board of Directors. Mr. Allingham previously served as Executive Vice President, Chief Financial Officer and General Manager of the Hyaluronan and Oral Restorative Divisions of Lifecore Biomedical. The Board of Directors of Lifecore Biomedical accepted the resignation of Dr. James W. Bracke, President, CEO and Director, who left to pursue other opportunities.
A copy of Lifecore’s press release is attached hereto as Exhibit (99.1) and hereby incorporated by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| | LIFECORE BIOMEDICAL, INC. |
| | |
Dated: February 10, 2004 | | /s/ Dennis J. Allingham |
| |
|
| | Dennis J. Allingham |
| | Chief Executive Officer, Chief Financial Officer and President |
Exhibit Index
99.1 Press release dated February 10, 2004